Daljit Singh Aurora

Insider Reports History

Location
Watertown, MA
Signature
/s/ Michael Milligan, as Attorney-in-Fact for Daljit Singh Aurora
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daljit Singh Aurora:

Company Role Class Num Shares Value Price $ Report Date Ownership
Neumora Therapeutics, Inc. Title: Chief Operating and Development Officer Common Stock 88,935 $161,861 $1.82 11 Nov 2025 Direct
Neumora Therapeutics, Inc. Title: Chief Operating and Development Officer Common Stock 0 $0 $2.68 11 Nov 2025 Indirect
Neumora Therapeutics, Inc. Title: Chief Operating and Development Officer Stock Option (Right to Buy) 750,000 08 Jan 2026 Direct
Neumora Therapeutics, Inc. Title: Chief Operating and Development Officer Stock Option (Right to Buy) 29,737 28 May 2025 Indirect

Insider Reports Filed by Daljit Singh Aurora

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NMRA Neumora Therapeutics, Inc. 08 Jan 2026 1 $0 4 Title: Chief Operating and Development Officer 09 Jan 2026, 16:19
NMRA Neumora Therapeutics, Inc. 11 Nov 2025 1 -$307,026 4 Title: Chief Operating and Development Officer 13 Nov 2025, 16:39
NMRA Neumora Therapeutics, Inc. 28 May 2025 16 $0 4 Title: Chief Operating and Development Officer 30 May 2025, 18:30
NMRA Neumora Therapeutics, Inc. 18 Feb 2025 1 -$14,347 4 Chief Strategy Officer 20 Feb 2025, 17:13
NMRA Neumora Therapeutics, Inc. 13 Feb 2025 15 $0 4 Title: Chief Operating and Development Officer 18 Feb 2025, 16:30
NMRA Neumora Therapeutics, Inc. 12 Sep 2024 6 $0 4 Chief Strategy Officer 13 Sep 2024, 17:22
NMRA Neumora Therapeutics, Inc. 22 Apr 2024 1 $0 4 Chief Strategy Officer 24 Apr 2024, 17:00
NMRA Neumora Therapeutics, Inc. 14 Feb 2024 2 $0 4 Chief Strategy Officer 16 Feb 2024, 16:20
NMRA Neumora Therapeutics, Inc. 14 Sep 2023 0 $0 3 Chief Strategy Officer 14 Sep 2023, 20:07